Adam C. Spice

CFO Adam C. Spice sold 62,744 shares for $8,945,631.27 via scheduled 10b5-1 plan on 2026-05-26.

Adam C. Spice, CFO of Rocket Lab Corp, executed 6 separate sales totaling 62,744 shares for $8,945,631.27 on 2026-05-26 at prices ranging from $139.41 to $144.13, reducing his holdings from 1,045,793 shares to 983,049 shares (-6.0%). The transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. At the time of sale, the stock was trading near its 52-week high of $151.00 (current price $148.03, -2.0% from peak), and the company's 90-day return stands at +114.2%, though the company remains unprofitable with negative net income of $-45,022,000.00 on revenue of $200,348,000.00. His prior sales at RKLB (5 trades on 2026-03-02) showed mixed 30-day results ranging from -7.2% to -2.0%, though 90-day results were consistently positive, ranging from +112.7% to +124.8%.

Rocket Lab CFO Spice sells 62,744 shares for $4.4M across 5 transactions on 2026-03-02, blended at $69.59

Adam C. Spice, Chief Financial Officer of Rocket Lab, executed 5 separate sales totaling 62,744 shares (62.7K shares) for $4,366,349.30 ($4.4M) on 2026-03-02, with a blended average price of $69.59. The CFO retains 1,296,824 shares (1.30M shares) post-transaction, representing a -4.6% reduction in holdings. At the time of sale, Rocket Lab traded 25.3% below its 52-week high of $96.30 and has declined 3.0% over the prior 30 days despite a 90-day gain of +45.7%. The company reported revenue of $155,080,000.00 ($155.1M) in its latest quarter but posted a net loss of $-18,257,000.00 ($-18.3M) and remains unprofitable on a full-year basis, though showing annual revenue growth of +38.0%. Across Spice's same-ticker history at RKLB, recent sells on 2026-01-05 show mixed post-transaction performance (ranging from +1.3% to -6.3% over 30 days), with no measurable 90-day outcomes yet available to assess timing quality at this stock.

CFO Spice sells 1.37M shares (50.1% of holdings) for $103.1M across 7 transactions on 2026-01-05

Rocket Lab's CFO Adam C. Spice executed 7 separate sales totaling 1,365,665 shares for $103,112,279.79 on 2026-01-05, reducing his post-transaction holdings to 1,359,568 shares—a 50.1% reduction of his pre-transaction position of 2,725,233 shares. The sales occurred across a price range of $72.15 to $78.04 with a blended average price of $75.50, all executed on the same day. This represents a material reduction in the CFO's ownership stake in the company. Given that the company generated quarterly revenue of $155,080,000.00 but reported a net loss of $-18,257,000.00 (and was unprofitable over its most recent full fiscal year), the timing of this large-scale insider sale merits investor attention. The current stock price of $86.03 represents a +0.0% position at the 52-week high, and over the 30-day period leading up to this sale, the stock had appreciated +75.4%—well above the insider's own cross-ticker historical average 90-day post-sell return of +22.9%, suggesting the stock may have experienced significant momentum prior to the sale.

CFO Spice sold 62,627 shares (62.6K) for $2,545,894.61 ($2.5M) on Nov 22–24 at $40.02–$41.35; stock down -34.0% in 30 days.

CFO Adam C. Spice executed 3 separate sales totaling 62,627 shares for $2,545,894.61 across November 22–24, 2025, reducing his holdings by 3.0% to 1,995,373 shares (2.00M shares). The sales occurred at prices ranging from $40.02 to $41.35 (blended $40.65), before the current price of $42.60. While the stock has declined -34.0% over the past 30 days and stands -38.5% from its 52-week high of $69.27, the CFO's prior trades at RKLB (5 recent sells in September) showed strong 30-day outcomes averaging +37.1% (range +35.6% to +40.2%), though measurable 90-day results are not yet available for those trades. This filing occurs as the company remains unprofitable (net income: $-18,257,000 on revenue of $155,080,000 for the latest quarter), though annual revenue growth reached +78.3%. The timing and magnitude of this multi-transaction sale merit examination given the recent volatility and the CFO's established pattern of selling in this stock.

CFO Adam C. Spice sells 874,588 shares (874.6K) in 2 transactions for $41,985,315.53, reducing holdings by -29.8%

Adam C. Spice, Chief Financial Officer of Rocket Lab Corp, executed 2 separate sales on 2025-09-19 totaling 874,588 shares at an average blended price of $48.01, generating $41,985,315.53 in proceeds and reducing his holdings from 2,932,477 shares to 2,057,889 shares. This represents a substantial -29.8% reduction in his stake. The company is unprofitable on a full-year basis (net income $-66,414,000.00) despite strong revenue growth of +78.3% year-over-year, indicating significant pre-profitability stage operations. This large-scale reduction by a senior financial officer at a growth-stage, unprofitable company warrants attention to understand the underlying motivation, particularly given the magnitude and timing relative to the company's fundamentals.

CFO Adam Spice sells 68,254 shares at blended average $48.97; holds 1,064,981 post-transaction while stock up 15.3% in 30 days.

Adam Spice, CFO of Rocket Lab, executed 5 separate sales totaling 68,254 shares for $3,342,240.37 at prices ranging from $47.78 to $51.63 on 2025-09-16. This represents a 6.0% reduction from his 1,133,235 pre-transaction holdings, leaving him with 1,064,981 shares—a substantial continued stake in the company. Notably, the stock has appreciated 15.3% over the past 30 days and 57.1% over the past 90 days, trading 12.7% below its 52-week high of $54.04. His prior RKLB-specific sells exhibit mixed timing: the 2025-05-30 sale saw the stock rise 79.7% in the 90-day window, while the 2025-03-14 and 2024-11-25 sales both posted positive 90-day returns, indicating only 1 of 3 prior same-ticker sales were well-timed. The company remains unprofitable (net income $-66,414,000.00 on revenue of $144,498,000.00), though annual revenue growth reached 78.3%, and the CFO maintains substantial ownership despite this disposition.

CFO Adam Spice sells 63,444 RKLB shares at $26.66; holds 1.13M shares post-sale

Adam Spice, Chief Financial Officer of Rocket Lab, sold 63,444 shares at $26.66 on 2025-05-30, reducing his holdings by 5.3% to 1,133,235 shares. The sale occurred at a price that is 15.4% below the 52-week high of $31.57, though the stock has gained 16.2% over the prior 30 days and 31.0% over 90 days. Across his cross-ticker selling history, Spice has demonstrated a 100% well-timed rate at the 90-day mark, and his prior two sales at RKLB showed strong 30-day returns (+8.0% and +10.2%); however, the company remains deeply unprofitable with a net loss of $60.6M against quarterly revenue of $122.6M. The sale's significance is neither routine nor dramatic—it represents a moderate portfolio adjustment by an executive at a volatile, loss-making growth company during a period of strong price momentum.

CFO Adam Spice sold 62,843 shares of RKLB at $18.18 on 2025-03-14; stock now -43.0% from 52-week high.

Adam Spice, CFO, executed a sale of 62,843 shares (62.8K shares) at $18.18 on 2025-03-14, reducing his position from 1,259,522 shares (1.26M shares) to 1,196,679 shares (1.20M shares), a reduction of 5.0%. The stock has declined significantly since the transaction, trading at $17.98 currently and down -43.0% from its 52-week high of $31.57. Notably, Spice's prior sell at RKLB (2024-11-25) exhibited a 90-day return of -2.5%, placing it in the well-timed category; his cross-ticker track record shows a 100.00% well-timed rate for sells based on 90-day outcomes. The company remains unprofitable (net income of $-51.9M on revenue of $104.8M), though annual revenue growth was strong at +78.3%, creating a mixed fundamental backdrop. This sale occurs against a backdrop of steep recent declines (-35.8% over 30 days, -21.6% over 90 days) and represents a material disposition by a senior financial executive whose prior execution at this ticker has proven timely at the quarterly mark.

RKLB CFO Adam Spice sold 62,511 shares at $24.15 on 2024-11-25 for $1,509,365.60, retaining 1,259,522 shares.

CFO Adam Spice sold 62,511 shares (-4.7% vs pre-transaction holdings) after the stock climbed 128.0% over 30 days and 312.0% over 90 days, reaching its 52-week high of $25.67. The sale occurred despite strong near-term momentum in a stock that has been highly volatile, and comes as Rocket Lab remains unprofitable with a negative net income of $-51,939,000.00 against quarterly revenue of $104,808,000.00. The CFO retained substantial holdings (1,259,522 shares post-transaction), but the discretionary nature of this sale—particularly during an exceptional rally—warrants monitoring given the company's ongoing operating losses.